VOYA INVESTMENT MANAGEMENT LLC - SERES THERAPEUTICS INC ownership

SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 152 filers reported holding SERES THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.

Quarter-by-quarter ownership
VOYA INVESTMENT MANAGEMENT LLC ownership history of SERES THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$96,466
-48.1%
40,532
+4.5%
0.00%
Q2 2023$185,814
+18.8%
38,792
+40.6%
0.00%
Q1 2023$156,430
+1.3%
27,5890.0%0.00%
Q4 2022$154,498
-12.8%
27,5890.0%0.00%
Q3 2022$177,121
+86.4%
27,5890.0%0.00%
Q2 2022$95,000
-51.5%
27,5890.0%0.00%
Q1 2022$196,000
-14.8%
27,5890.0%0.00%
Q4 2021$230,000
+21.1%
27,589
+0.9%
0.00%
Q3 2021$190,000
-70.9%
27,3360.0%0.00%
-100.0%
Q2 2021$652,000
+32.0%
27,336
+14.0%
0.00%0.0%
Q1 2021$494,000
-14.2%
23,989
+2.0%
0.00%0.0%
Q4 2020$576,000
+13.4%
23,512
+31.2%
0.00%0.0%
Q3 2020$508,000
+586.5%
17,927
+15.1%
0.00%
Q2 2020$74,000
+7.2%
15,573
-19.2%
0.00%
Q1 2020$69,000
+3.0%
19,2790.0%0.00%
Q4 2019$67,000
+21.8%
19,279
+41.0%
0.00%
Q3 2019$55,000
+66.7%
13,670
+35.1%
0.00%
Q2 2019$33,000
-52.2%
10,1150.0%0.00%
Q1 2019$69,000
+50.0%
10,1150.0%0.00%
Q4 2018$46,000
-40.3%
10,1150.0%0.00%
Q3 2018$77,000
-11.5%
10,1150.0%0.00%
Q2 2018$87,000
+17.6%
10,1150.0%0.00%
Q1 2018$74,000
-28.2%
10,1150.0%0.00%
Q4 2017$103,000
-36.4%
10,1150.0%0.00%
Q3 2017$162,000
+42.1%
10,1150.0%0.00%
Q2 2017$114,000
-49.6%
10,115
+30.1%
0.00%
-100.0%
Q2 2016$226,0007,7720.00%
Other shareholders
SERES THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 23,117,045$55,018,5673.99%
Lion Point Capital, LP 691,803$1,646,4910.73%
Eversept Partners, LP 2,352,556$5,599,0830.47%
Soleus Capital Management, L.P. 1,820,983$4,333,9400.40%
Simplify Asset Management Inc. 550,626$1,310,4900.15%
Avoro Capital Advisors LLC 2,500,000$5,950,0000.09%
IRONWOOD INVESTMENT MANAGEMENT LLC 45,419$108,0970.07%
Knott David M Jr 70,000$1670.06%
XTX Topco Ltd 150,097$357,2310.06%
FEDERATED HERMES, INC. 8,981,717$21,376,4860.06%
View complete list of SERES THERAPEUTICS INC shareholders